1. Home
  2. BRTX vs DTSS Comparison

BRTX vs DTSS Comparison

Compare BRTX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.26

Market Cap

9.3M

Sector

Health Care

ML Signal

HOLD

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$1.00

Market Cap

9.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRTX
DTSS
Founded
1997
2014
Country
United States
China
Employees
N/A
N/A
Industry
Managed Health Care
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
9.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BRTX
DTSS
Price
$0.26
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
827.5K
131.5K
Earning Date
03-26-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$383,400.00
$64,349,277.00
Revenue This Year
$112.14
N/A
Revenue Next Year
$139.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.70
68.56
52 Week Low
$0.22
$0.64
52 Week High
$2.50
$2.89

Technical Indicators

Market Signals
Indicator
BRTX
DTSS
Relative Strength Index (RSI) 11.42 48.02
Support Level $0.22 $0.97
Resistance Level $1.13 $1.15
Average True Range (ATR) 0.09 0.15
MACD -0.10 -0.01
Stochastic Oscillator 3.22 23.28

Price Performance

Historical Comparison
BRTX
DTSS

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

Share on Social Networks: